A recent Lancet editorial addresses the retraction by BioMed Central of 42 articles published by medical researchers in China. The fraudulent articles emanate from prestigious centres in many parts of the country. This information furnishes a possible explanation for the finding that effectiveness studies that provide null results in North America often provide positive results in China.
— Richard Lilford, CLAHRC WM Director
- The Lancet. China’s medical research integrity questioned. Lancet. 2015; 385:1365.
- Hartley LC, Girling AJ, Bowater RJ, Lilford RJ. A multi-study analysis investigating systematic differences in cardiovascular trial results between Europe and Asia. J Epidemiol Comm H. [ePub].